Literature DB >> 33464460

Progress Report: New insights into the prevention of CRC by colonoscopic surveillance in Lynch syndrome.

Hans F A Vasen1.   

Abstract

Lynch syndrome is the most frequent hereditary colorectal cancer (CRC) syndrome, affecting approximately 1 in 300 in the Western population. It is caused by pathogenic variants in the mismatch repair (MMR) genes including MLH1, MSH2 (EPCAM), MSH6 and PMS2, and is associated with high risks of CRC, endometrial cancer and other cancers. In view of these risks, carriers of such variants are encouraged to participate in colonoscopic surveillance programs that are known to substantially improve their prognosis. In the last decade several important studies have been published that provide detailed cancer risk estimates and prognoses based on large numbers of patients. These studies also provided new insights regarding the pathways of carcinogenesis in CRC, which appear to differ depending on the specific MMR gene defect. In this report, we will discuss the implications of these new findings for the development of new surveillance protocols.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Entities:  

Keywords:  Hereditary colorectal cancer; Lynch syndrome; Pathways carcinogenesis; Surveillance; “de novo” colorectal cancer

Mesh:

Substances:

Year:  2021        PMID: 33464460     DOI: 10.1007/s10689-020-00225-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  53 in total

Review 1.  Recent advances in Lynch syndrome.

Authors:  Leah H Biller; Sapna Syngal; Matthew B Yurgelun
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

2.  Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands.

Authors:  H F Vasen; F C den Hartog Jager; F H Menko; F M Nagengast
Journal:  Am J Med       Date:  1989-03       Impact factor: 4.965

3.  Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome)

Authors:  H F Vasen; F M Nagengast; P M Khan
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

4.  Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; J P Mecklin; P Sistonen
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

Review 5.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.

Authors:  H T Lynch; T C Smyrk; P Watson; S J Lanspa; J F Lynch; P M Lynch; R J Cavalieri; C R Boland
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

Review 6.  Role of new endoscopic techniques in Lynch syndrome.

Authors:  Jasmijn F Haanstra; Jan H Kleibeuker; Jan J Koornstra
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

7.  Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II).

Authors:  H T Lynch; P Watson; S J Lanspa; J Marcus; T Smyrk; R J Fitzgibbons; M Kriegler; J F Lynch
Journal:  Dis Colon Rectum       Date:  1988-06       Impact factor: 4.585

8.  Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.

Authors:  Christoph Engel; Nils Rahner; Karsten Schulmann; Elke Holinski-Feder; Timm O Goecke; Hans K Schackert; Matthias Kloor; Verena Steinke; Holger Vogelsang; Gabriela Möslein; Heike Görgens; Stefan Dechant; Magnus von Knebel Doeberitz; Josef Rüschoff; Nicolaus Friedrichs; Reinhard Büttner; Markus Loeffler; Peter Propping; Wolff Schmiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-14       Impact factor: 11.382

9.  Screening for colorectal carcinoma in cancer family syndrome kindreds.

Authors:  J P Mecklin; H J Järvinen; S Aukee; I Elomaa; K Karjalainen
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

10.  Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.

Authors:  Mev Dominguez-Valentin; Julian R Sampson; Toni T Seppälä; Sanne W Ten Broeke; John-Paul Plazzer; Sigve Nakken; Christoph Engel; Stefan Aretz; Mark A Jenkins; Lone Sunde; Inge Bernstein; Gabriel Capella; Francesc Balaguer; Huw Thomas; D Gareth Evans; John Burn; Marc Greenblatt; Eivind Hovig; Wouter H de Vos Tot Nederveen Cappel; Rolf H Sijmons; Lucio Bertario; Maria Grazia Tibiletti; Giulia Martina Cavestro; Annika Lindblom; Adriana Della Valle; Francisco Lopez-Köstner; Nathan Gluck; Lior H Katz; Karl Heinimann; Carlos A Vaccaro; Reinhard Büttner; Heike Görgens; Elke Holinski-Feder; Monika Morak; Stefanie Holzapfel; Robert Hüneburg; Magnus von Knebel Doeberitz; Markus Loeffler; Nils Rahner; Hans K Schackert; Verena Steinke-Lange; Wolff Schmiegel; Deepak Vangala; Kirsi Pylvänäinen; Laura Renkonen-Sinisalo; John L Hopper; Aung Ko Win; Robert W Haile; Noralane M Lindor; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; Jane C Figueiredo; Stephen N Thibodeau; Karin Wadt; Christina Therkildsen; Henrik Okkels; Zohreh Ketabi; Leticia Moreira; Ariadna Sánchez; Miquel Serra-Burriel; Marta Pineda; Matilde Navarro; Ignacio Blanco; Kate Green; Fiona Lalloo; Emma J Crosbie; James Hill; Oliver G Denton; Ian M Frayling; Einar Andreas Rødland; Hans Vasen; Miriam Mints; Florencia Neffa; Patricia Esperon; Karin Alvarez; Revital Kariv; Guy Rosner; Tamara Alejandra Pinero; María Laura Gonzalez; Pablo Kalfayan; Douglas Tjandra; Ingrid M Winship; Finlay Macrae; Gabriela Möslein; Jukka-Pekka Mecklin; Maartje Nielsen; Pål Møller
Journal:  Genet Med       Date:  2019-07-24       Impact factor: 8.822

View more
  2 in total

1.  MutL homolog 1 germline mutation c.(453+1_454-1)_(545+1_546-1)del identified in lynch syndrome: A case report and review of literature.

Authors:  Xi-Wen Zhang; Zan-Hui Jia; Li-Ping Zhao; Yi-Shi Wu; Man-Hua Cui; Yan Jia; Tian-Min Xu
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

Review 2.  Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.

Authors:  Davide Serrano; Paola Patrignani; Vittoria Stigliano; Daniela Turchetti; Stefania Sciallero; Franco Roviello; Alessandro D'Arpino; Ignazio Grattagliano; Salvo Testa; Cristina Oliani; Lucio Bertario; Bernardo Bonanni
Journal:  Genes (Basel)       Date:  2022-03-03       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.